Name | [4-(3-fluoroanilino)piperidin-1-yl]-(1H-imidazol-2-yl)methanone |
---|
Molecular Formula | C15H17FN4O |
---|---|
Molecular Weight | 288.32000 |
Exact Mass | 288.13900 |
PSA | 61.02000 |
LogP | 2.27640 |
~% 920511-25-7 |
Literature: Glaxo Group Limited Patent: US2008/312209 A1, 2008 ; Location in patent: Page/Page column 18 ; US 20080312209 A1 |
~54% 920511-25-7 |
Literature: Westaway, Susan M.; Brown, Samantha L.; Conway, Elizabeth; Heightman, Tom D.; Johnson, Christopher N.; Lapsley, Kate; Macdonald, Gregor J.; MacPherson, David T.; Mitchell, Darren J.; Myatt, James W.; Seal, Jon T.; Stanway, Steven J.; Stemp, Geoffrey; Thompson, Mervyn; Celestini, Paolo; Colombo, Andrea; Consonni, Alessandra; Gagliardi, Stefania; Riccaboni, Mauro; Ronzoni, Silvano; Briggs, Michael A.; Matthews, Kim L.; Stevens, Alexander J.; Bolton, Victoria J.; Boyfield, Izzy; Jarvie, Emma M.; Stratton, Sharon C.; Sanger, Gareth J. Bioorganic and Medicinal Chemistry Letters, 2008 , vol. 18, # 24 p. 6429 - 6436 |